By Helgi Analytics - October 25, 2022
Chirana T. Injecta Group made a net profit of EUR 1.88 mil with revenues of EUR 50.5 mil in 2021, up by 17.1% and up by...
By Helgi Analytics - October 25, 2022
Chirana T. Injecta Group stock traded at EUR 29.5 per share at the end 2021 translating into a market capitalization of USD 34.6 mil. ...
By Helgi Analytics - October 25, 2022
Chirana T. Injecta Group stock traded at EUR 29.5 per share at the end 2021 implying a market capitalization of USD 34.6 mil. Sin...
| Profit Statement | 2019 | 2020 | 2021 | |
| Sales | EUR mil | 41.9 | 42.8 | 50.5 |
| Gross Profit | EUR mil | 11.0 | 20.1 | 23.5 |
| EBITDA | EUR mil | 5.67 | 5.17 | 5.78 |
| EBIT | EUR mil | 2.53 | 2.08 | 2.70 |
| Financing Cost | EUR mil | 0.315 | 0 | 0.250 |
| Pre-Tax Profit | EUR mil | 2.22 | 2.08 | 2.44 |
| Net Profit | EUR mil | 1.74 | 1.60 | 1.88 |
| Dividends | EUR mil | 0 | 0 | 1.90 |
| Balance Sheet | 2019 | 2020 | 2021 | |
| Total Assets | EUR mil | 57.4 | 54.1 | 60.0 |
| Non-Current Assets | EUR mil | 31.1 | 29.6 | 30.7 |
| Current Assets | EUR mil | 26.3 | 24.5 | 29.3 |
| Working Capital | EUR mil | 16.2 | 16.6 | 17.3 |
| Shareholders' Equity | EUR mil | 33.5 | 35.3 | 37.9 |
| Liabilities | EUR mil | 23.9 | 18.8 | 22.1 |
| Total Debt | EUR mil | 11.4 | 9.68 | 9.02 |
| Net Debt | EUR mil | 10.2 | 7.78 | 7.08 |
| Ratios | 2019 | 2020 | 2021 | |
| ROE | % | 5.33 | 4.66 | 5.13 |
| ROCE | % | 3.75 | 3.43 | 3.99 |
| Gross Margin | % | 26.2 | 47.0 | 46.5 |
| EBITDA Margin | % | 13.5 | 12.1 | 11.5 |
| EBIT Margin | % | 6.04 | 4.87 | 5.35 |
| Net Margin | % | 4.15 | 3.75 | 3.72 |
| Net Debt/EBITDA | 1.80 | 1.50 | 1.23 | |
| Net Debt/Equity | % | 30.5 | 22.0 | 18.7 |
| Cost of Financing | % | 2.79 | 0 | 2.67 |
| Valuation | 2019 | 2020 | 2021 | |
| Market Capitalisation | USD mil | 33.1 | 36.1 | 34.6 |
| Enterprise Value (EV) | USD mil | 44.6 | 45.6 | 42.9 |
| Number Of Shares | mil | 1.00 | 1.00 | 1.00 |
| Share Price | EUR | 29.5 | 29.5 | 29.5 |
| EV/EBITDA | 6.93 | 7.54 | 6.20 | |
| EV/Sales | 0.939 | 0.910 | 0.710 | |
| Price/Earnings (P/E) | 17.0 | 18.4 | 15.7 | |
| Price/Book Value (P/BV) | 0.882 | 0.835 | 0.780 | |
| Dividend Yield | % | 0 | 0 | 6.44 |
Get all company financials in excel:
| overview | Unit | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
| income statement | |||||||||||||||||||
| Sales | EUR mil | 32.3 | 33.3 | 34.9 | 41.9 | 42.8 | |||||||||||||
| Gross Profit | EUR mil | 12.6 | 14.0 | 14.7 | 11.0 | 20.1 | |||||||||||||
| EBIT | EUR mil | 1.61 | 2.61 | 2.43 | 2.53 | 2.08 | |||||||||||||
| Net Profit | EUR mil | 1.13 | 1.69 | 1.86 | 1.74 | 1.60 | |||||||||||||
| ROE | % | ... | 4.02 | 5.72 | 6.04 | 5.33 | 4.66 | ||||||||||||
| EBIT Margin | % | 4.99 | 7.85 | 6.96 | 6.04 | 4.87 | |||||||||||||
| Net Margin | % | 3.49 | 5.07 | 5.33 | 4.15 | 3.75 | |||||||||||||
| Employees | ... | ... | ... | ... | ... | ... | ... | ... | ... | 434 | 204 | ... | ... | ... | ... | ... | ... | ... | |
| balance sheet | |||||||||||||||||||
| Total Assets | EUR mil | 52.5 | 51.4 | 52.3 | 57.4 | 54.1 | |||||||||||||
| Non-Current Assets | EUR mil | 35.8 | 34.7 | 33.6 | 31.1 | 29.6 | |||||||||||||
| Current Assets | EUR mil | 16.7 | 16.7 | 18.6 | 26.3 | 24.5 | |||||||||||||
| Shareholders' Equity | EUR mil | 29.1 | 29.9 | 31.7 | 33.5 | 35.3 | |||||||||||||
| Liabilities | EUR mil | 23.4 | 21.5 | 20.5 | 23.9 | 18.8 | |||||||||||||
| Non-Current Liabilities | EUR mil | 12.4 | 9.30 | 6.75 | 6.39 | 5.19 | |||||||||||||
| Current Liabilities | EUR mil | 11.9 | 12.2 | 13.8 | 17.6 | 13.6 | |||||||||||||
| Net Debt/EBITDA | 2.72 | 2.14 | 1.61 | 1.80 | 1.50 | ||||||||||||||
| Net Debt/Equity | % | 47.9 | 43.7 | 31.9 | 30.5 | 22.0 | |||||||||||||
| Cost of Financing | % | ... | 2.49 | 2.79 | 1.52 | 2.79 | 0 | ||||||||||||
| cash flow | |||||||||||||||||||
| Total Cash From Operations | EUR mil | ... | 3.42 | 3.75 | 3.27 | 0.979 | 4.30 | ||||||||||||
| Total Cash From Investing | EUR mil | ... | -0.844 | -1.43 | -1.06 | -0.376 | -1.00 | ||||||||||||
| Total Cash From Financing | EUR mil | ... | -2.82 | -1.96 | -2.20 | -0.548 | -1.68 | ||||||||||||
| Net Change In Cash | EUR mil | ... | -0.241 | 0.353 | 0.009 | 0.055 | 0.743 | ||||||||||||
| valuation | |||||||||||||||||||
| Market Capitalisation | USD mil | ... | ... | ... | ... | ... | ... | ... | 31.2 | 35.4 | 33.8 | 33.1 | 36.1 | ||||||
| Enterprise Value (EV) | USD mil | ... | ... | ... | ... | ... | ... | ... | 45.9 | 51.1 | 45.4 | 44.6 | 45.6 | ||||||
| Number Of Shares | mil | ... | ... | ... | ... | ... | ... | ... | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | ||||||
| Share Price | EUR | ... | ... | ... | ... | ... | ... | ... | 29.5 | 29.5 | 29.5 | 29.5 | 29.5 | ||||||
| Price/Earnings (P/E) | ... | ... | ... | ... | ... | ... | ... | 26.2 | 17.5 | 15.9 | 17.0 | 18.4 | |||||||
| Price/Cash Earnings (P/CE) | ... | ... | ... | ... | ... | ... | ... | 6.35 | 5.68 | 5.32 | 6.05 | 6.29 | |||||||
| EV/EBITDA | ... | ... | ... | ... | ... | ... | ... | 8.34 | 7.43 | 6.15 | 6.93 | 7.54 | |||||||
| Price/Book Value (P/BV) | ... | ... | ... | ... | ... | ... | ... | 1.01 | 0.987 | 0.931 | 0.882 | 0.835 | |||||||
| Dividend Yield | % | ... | ... | ... | ... | ... | ... | ... | ... | ... | 0 | 0 | 0 |
| income statement | Unit | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
| income statement | |||||||||||||||||||
| Sales | EUR mil | 32.3 | 33.3 | 34.9 | 41.9 | 42.8 | |||||||||||||
| Cost of Goods & Services | EUR mil | 19.6 | 19.3 | 20.1 | 30.9 | 22.7 | |||||||||||||
| Gross Profit | EUR mil | 12.6 | 14.0 | 14.7 | 11.0 | 20.1 | |||||||||||||
| Staff Cost | EUR mil | 7.85 | 8.68 | 9.61 | 6.42 | 11.2 | |||||||||||||
| Other Operating Cost (Income) | EUR mil | -0.345 | -0.838 | -1.17 | -1.11 | 3.76 | |||||||||||||
| EBITDA | EUR mil | 5.14 | 6.12 | 6.30 | 5.67 | 5.17 | |||||||||||||
| Depreciation | EUR mil | 3.52 | 3.51 | 3.69 | 3.14 | 3.09 | |||||||||||||
| EBIT | EUR mil | 1.61 | 2.61 | 2.43 | 2.53 | 2.08 | |||||||||||||
| Net Financing Cost | EUR mil | 0.392 | 0.402 | 0.193 | 0.315 | 0 | |||||||||||||
| Financing Cost | EUR mil | 0.392 | 0.402 | 0.193 | 0.315 | 0 | |||||||||||||
| Extraordinary Cost | EUR mil | -0.258 | -0.033 | -0.178 | 0 | 0 | |||||||||||||
| Pre-Tax Profit | EUR mil | 1.48 | 2.24 | 2.41 | 2.22 | 2.08 | |||||||||||||
| Tax | EUR mil | 0.351 | 0.557 | 0.553 | 0.477 | 0.479 | |||||||||||||
| Minorities | EUR mil | 0 | 0 | 0 | 0 | 0 | |||||||||||||
| Net Profit | EUR mil | 1.13 | 1.69 | 1.86 | 1.74 | 1.60 | |||||||||||||
| Net Profit Avail. to Common | EUR mil | 1.13 | 1.69 | 1.86 | 1.74 | 1.60 | |||||||||||||
| Dividends | EUR mil | ... | ... | ... | ... | ... | ... | ... | ... | ... | 0 | 0 | 0 | ||||||
| growth rates | |||||||||||||||||||
| Total Revenue Growth | % | ... | -3.60 | 3.07 | 4.79 | 20.1 | 2.24 | ||||||||||||
| Staff Cost Growth | % | ... | 1.47 | 10.6 | 10.7 | -33.2 | 74.3 | ||||||||||||
| EBITDA Growth | % | ... | -33.0 | 19.2 | 2.91 | -9.96 | -8.83 | ||||||||||||
| EBIT Growth | % | ... | -62.5 | 0 | ... | 4.24 | -17.6 | ||||||||||||
| Pre-Tax Profit Growth | % | ... | -63.9 | 51.8 | 7.49 | -8.17 | -5.90 | ||||||||||||
| Net Profit Growth | % | ... | -63.4 | 49.7 | 10.2 | -6.51 | -7.66 | ||||||||||||
| ratios | |||||||||||||||||||
| ROE | % | ... | 4.02 | 5.72 | 6.04 | 5.33 | 4.66 | ||||||||||||
| ROA | % | ... | 2.12 | 3.25 | 3.59 | 3.17 | 2.88 | ||||||||||||
| ROCE | % | ... | 2.38 | 3.64 | 4.08 | 3.75 | 3.43 | ||||||||||||
| Gross Margin | % | 39.2 | 42.0 | 42.3 | 26.2 | 47.0 | |||||||||||||
| EBITDA Margin | % | 15.9 | 18.4 | 18.1 | 13.5 | 12.1 | |||||||||||||
| EBIT Margin | % | 4.99 | 7.85 | 6.96 | 6.04 | 4.87 | |||||||||||||
| Net Margin | % | 3.49 | 5.07 | 5.33 | 4.15 | 3.75 | |||||||||||||
| Payout Ratio | % | ... | ... | ... | ... | ... | ... | ... | ... | ... | 0 | 0 | 0 | ||||||
| Cost of Financing | % | ... | 2.49 | 2.79 | 1.52 | 2.79 | 0 | ||||||||||||
| Net Debt/EBITDA | 2.72 | 2.14 | 1.61 | 1.80 | 1.50 |
| balance sheet | Unit | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
| balance sheet | |||||||||||||||||||
| Cash & Cash Equivalents | EUR mil | 0.743 | 1.10 | 1.11 | 1.16 | 1.90 | |||||||||||||
| Receivables | EUR mil | 6.69 | 7.23 | 7.22 | 15.7 | 13.2 | |||||||||||||
| Inventories | EUR mil | 9.27 | 8.38 | 10.0 | 9.28 | 9.25 | |||||||||||||
| Other ST Assets | EUR mil | < 0.001 | < -0.001 | 0.297 | 0.211 | 0.170 | |||||||||||||
| Current Assets | EUR mil | 16.7 | 16.7 | 18.6 | 26.3 | 24.5 | |||||||||||||
| Property, Plant & Equipment | EUR mil | 17.5 | 15.3 | 14.2 | 14.0 | 12.9 | |||||||||||||
| LT Investments & Receivables | EUR mil | 3.44 | 4.38 | 4.63 | 2.35 | 1.95 | |||||||||||||
| Intangible Assets | EUR mil | 14.9 | 15.0 | 14.8 | 14.8 | 14.8 | |||||||||||||
| Goodwill | EUR mil | 14.8 | 14.8 | 14.8 | 14.8 | 14.8 | |||||||||||||
| Non-Current Assets | EUR mil | 35.8 | 34.7 | 33.6 | 31.1 | 29.6 | |||||||||||||
| Total Assets | EUR mil | 52.5 | 51.4 | 52.3 | 57.4 | 54.1 | |||||||||||||
| Trade Payables | EUR mil | 4.84 | 4.64 | 5.52 | 8.80 | 5.84 | |||||||||||||
| Short-Term Debt | EUR mil | 6.37 | 6.84 | 7.52 | 8.00 | 7.00 | |||||||||||||
| Other ST Liabilities | EUR mil | 0.743 | 0.756 | 0.756 | 0.756 | 0.756 | |||||||||||||
| Current Liabilities | EUR mil | 11.9 | 12.2 | 13.8 | 17.6 | 13.6 | |||||||||||||
| Long-Term Debt | EUR mil | 8.33 | 7.32 | 3.71 | 3.36 | 2.68 | |||||||||||||
| Other LT Liabilities | EUR mil | 4.10 | 1.98 | 3.04 | 3.03 | 2.51 | |||||||||||||
| Non-Current Liabilities | EUR mil | 12.4 | 9.30 | 6.75 | 6.39 | 5.19 | |||||||||||||
| Liabilities | EUR mil | 23.4 | 21.5 | 20.5 | 23.9 | 18.8 | |||||||||||||
| Equity Before Minority Interest | EUR mil | 29.1 | 29.9 | 31.7 | 33.5 | 35.3 | |||||||||||||
| Minority Interest | EUR mil | 0 | 0 | 0 | 0 | 0 | |||||||||||||
| Equity | EUR mil | 29.1 | 29.9 | 31.7 | 33.5 | 35.3 | |||||||||||||
| growth rates | |||||||||||||||||||
| Total Asset Growth | % | ... | -2.07 | -2.00 | 1.59 | 9.91 | -5.75 | ||||||||||||
| Shareholders' Equity Growth | % | ... | 7.87 | 2.70 | 6.07 | 5.61 | 5.53 | ||||||||||||
| Net Debt Growth | % | ... | -11.9 | -6.32 | -22.5 | 0.688 | -23.8 | ||||||||||||
| Total Debt Growth | % | ... | -12.6 | -3.60 | -20.7 | 1.11 | -14.8 | ||||||||||||
| ratios | |||||||||||||||||||
| Total Debt | EUR mil | 14.7 | 14.2 | 11.2 | 11.4 | 9.68 | |||||||||||||
| Net Debt | EUR mil | 14.0 | 13.1 | 10.1 | 10.2 | 7.78 | |||||||||||||
| Working Capital | EUR mil | 11.1 | 11.0 | 11.7 | 16.2 | 16.6 | |||||||||||||
| Capital Employed | EUR mil | 46.9 | 45.7 | 45.3 | 47.3 | 46.2 | |||||||||||||
| Net Debt/Equity | % | 47.9 | 43.7 | 31.9 | 30.5 | 22.0 | |||||||||||||
| Current Ratio | 1.40 | 1.37 | 1.35 | 1.50 | 1.80 | ||||||||||||||
| Quick Ratio | 0.622 | 0.681 | 0.604 | 0.960 | 1.11 |
| cash flow | Unit | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
| cash flow | |||||||||||||||||||
| Net Profit | EUR mil | 1.13 | 1.69 | 1.86 | 1.74 | 1.60 | |||||||||||||
| Depreciation | EUR mil | 3.52 | 3.51 | 3.69 | 3.14 | 3.09 | |||||||||||||
| Non-Cash Items | EUR mil | ... | -2.69 | -1.60 | -1.55 | 0.554 | 0 | ||||||||||||
| Change in Working Capital | EUR mil | ... | 1.46 | 0.156 | -0.738 | -4.46 | -0.396 | ||||||||||||
| Total Cash From Operations | EUR mil | ... | 3.42 | 3.75 | 3.27 | 0.979 | 4.30 | ||||||||||||
| Capital Expenditures | EUR mil | ... | -1.03 | -1.87 | -1.45 | -0.379 | -1.00 | ||||||||||||
| Other Investing Activities | EUR mil | ... | 0.190 | 0.432 | 0.391 | 0 | 0 | ||||||||||||
| Total Cash From Investing | EUR mil | ... | -0.844 | -1.43 | -1.06 | -0.376 | -1.00 | ||||||||||||
| Dividends Paid | EUR mil | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | 0 | 0 | ||||||
| Issuance Of Debt | EUR mil | ... | -2.13 | -0.529 | -2.93 | 0.125 | -1.68 | ||||||||||||
| Total Cash From Financing | EUR mil | ... | -2.82 | -1.96 | -2.20 | -0.548 | -1.68 | ||||||||||||
| Net Change In Cash | EUR mil | ... | -0.241 | 0.353 | 0.009 | 0.055 | 0.743 | ||||||||||||
| ratios | |||||||||||||||||||
| Days Sales Outstanding | days | 75.7 | 79.4 | 75.6 | 137 | 112 | |||||||||||||
| Days Sales Of Inventory | days | 172 | 158 | 181 | 110 | 149 | |||||||||||||
| Days Payable Outstanding | days | 89.9 | 87.7 | 100 | 104 | 94.0 | |||||||||||||
| Cash Conversion Cycle | days | 158 | 150 | 157 | 142 | 167 | |||||||||||||
| Cash Earnings | EUR mil | 4.65 | 5.20 | 5.55 | 4.88 | 4.69 | |||||||||||||
| Free Cash Flow | EUR mil | ... | 2.58 | 2.32 | 2.21 | 0.603 | 3.30 | ||||||||||||
| Capital Expenditures (As % of Sales) | % | ... | 3.20 | 5.61 | 4.15 | 0.905 | 2.34 |
| other ratios | Unit | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
| Employees | ... | ... | ... | ... | ... | ... | ... | ... | ... | 434 | 204 | ... | ... | ... | ... | ... | ... | ... | |
| Cost Per Employee | USD per month | ... | ... | ... | ... | ... | ... | ... | ... | ... | 2,161 | 2,972 | ... | ... | ... | ... | ... | ... | ... |
| Cost Per Employee (Local Currency) | EUR per month | ... | ... | ... | ... | ... | ... | ... | ... | ... | 1,845 | 2,623 | ... | ... | ... | ... | ... | ... | ... |
| Staff Cost (As % of Sales) | % | 24.3 | 26.1 | 27.6 | 15.3 | 26.1 | |||||||||||||
| Effective Tax Rate | % | 23.7 | 24.8 | 22.9 | 21.5 | 23.0 | |||||||||||||
| Total Revenue Growth (5-year average) | % | ... | ... | ... | ... | ... | 2.50 | 2.40 | 3.16 | 4.80 | 5.04 | ||||||||
| Total Revenue Growth (10-year average) | % | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | 8.14 | 7.57 |
| valuation | Unit | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
| Market Capitalisation | USD mil | ... | ... | ... | ... | ... | ... | ... | 31.2 | 35.4 | 33.8 | 33.1 | 36.1 | ||||||
| Enterprise Value (EV) | USD mil | ... | ... | ... | ... | ... | ... | ... | 45.9 | 51.1 | 45.4 | 44.6 | 45.6 | ||||||
| Number Of Shares | mil | ... | ... | ... | ... | ... | ... | ... | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | ||||||
| Share Price | EUR | ... | ... | ... | ... | ... | ... | ... | 29.5 | 29.5 | 29.5 | 29.5 | 29.5 | ||||||
| EV/EBITDA | ... | ... | ... | ... | ... | ... | ... | 8.34 | 7.43 | 6.15 | 6.93 | 7.54 | |||||||
| Price/Earnings (P/E) | ... | ... | ... | ... | ... | ... | ... | 26.2 | 17.5 | 15.9 | 17.0 | 18.4 | |||||||
| Price/Cash Earnings (P/CE) | ... | ... | ... | ... | ... | ... | ... | 6.35 | 5.68 | 5.32 | 6.05 | 6.29 | |||||||
| P/FCF | ... | ... | ... | ... | ... | ... | ... | 11.5 | 12.7 | 13.3 | 49.0 | 8.96 | |||||||
| Price/Book Value (P/BV) | ... | ... | ... | ... | ... | ... | ... | 1.01 | 0.987 | 0.931 | 0.882 | 0.835 | |||||||
| Dividend Yield | % | ... | ... | ... | ... | ... | ... | ... | ... | ... | 0 | 0 | 0 | ||||||
| Free Cash Flow Yield | % | ... | ... | ... | ... | ... | ... | ... | 8.87 | 7.35 | 7.67 | 2.06 | 10.7 | ||||||
| Earnings Per Share (EPS) | EUR | ... | ... | ... | ... | ... | ... | ... | 1.13 | 1.69 | 1.86 | 1.74 | 1.60 | ||||||
| Cash Earnings Per Share | EUR | ... | ... | ... | ... | ... | ... | ... | 4.65 | 5.20 | 5.55 | 4.88 | 4.69 | ||||||
| Free Cash Flow Per Share | EUR | ... | ... | ... | ... | ... | ... | ... | 2.58 | 2.32 | 2.21 | 0.603 | 3.30 | ||||||
| Book Value Per Share | EUR | ... | ... | ... | ... | ... | ... | ... | 29.1 | 29.9 | 31.7 | 33.5 | 35.3 | ||||||
| Dividend Per Share | EUR | ... | ... | ... | ... | ... | ... | ... | ... | ... | 0 | 0 | 0 | ||||||
| EV/Sales | ... | ... | ... | ... | ... | ... | ... | 1.33 | 1.37 | 1.11 | 0.939 | 0.910 | |||||||
| EV/EBIT | ... | ... | ... | ... | ... | ... | ... | 26.6 | 17.4 | 16.0 | 15.5 | 18.7 | |||||||
| EV/Free Cash Flow | ... | ... | ... | ... | ... | ... | ... | 16.6 | 19.6 | 17.5 | 65.2 | 11.8 | |||||||
| EV/Capital Employed | ... | ... | ... | ... | ... | ... | ... | 0.927 | 0.932 | 0.875 | 0.840 | 0.807 | |||||||
| Earnings Per Share Growth | % | ... | ... | ... | ... | ... | ... | ... | ... | 49.7 | 10.2 | -6.51 | -7.66 | ||||||
| Cash Earnings Per Share Growth | % | ... | ... | ... | ... | ... | ... | ... | ... | 11.7 | 6.89 | -12.1 | -3.90 | ||||||
| Book Value Per Share Growth | % | ... | ... | ... | ... | ... | ... | ... | ... | 2.70 | 6.07 | 5.61 | 5.53 |
Get all company financials in excel:
By Helgi Analytics - October 25, 2022
Chirana T. Injecta Group made a net profit of EUR 1.88 mil with revenues of EUR 50.5 mil in 2021, up by 17.1% and up by 17.9%, respectively, compared to the previous year. This translates into a net margin of 3.72%. Historically, between 2009 and 2021, ...
By Helgi Analytics - October 25, 2022
Chirana T. Injecta Group invested a total of EUR 1.50 mil in 2021, up 50% compared to the previous year. Historically, between 2010 - 2021, the company's investments stood at a high of EUR 4.15 mil in 2014 and a low of EUR 0.088 mil in 2010....
By Helgi Analytics - October 25, 2022
Chirana T. Injecta Group made a net profit of EUR 1.88 mil in 2021, up 17.1% compared to the previous year. Historically, between 2009 and 2021, the company's net profit reached a high of EUR 6.09 mil in 2012 and a low of EUR 1.13 mil in 2016. The result ...
By Helgi Analytics - October 25, 2022
Chirana T. Injecta Group's net debt stood at EUR 7.08 mil and accounted for 18.7% of equity at the end of 2021. The ratio is down 3.29 pp compared to the previous year. Historically, the firm’s net debt to equity reached a high of 99.6% in 2009 and ...
By Helgi Analytics - October 25, 2022
Chirana T. Injecta Group stock traded at EUR 29.5 per share at the end 2021 translating into a market capitalization of USD 34.6 mil. Since the end of 2016, the stock has appreciated by 0% representing an annual average growth of 0%. At the end of 2021, ...
Chirana T. Injecta Group has been growing its sales by 4.02% a year on average in the last 5 years. EBITDA has grown on average by 12.7% a year during that time to total of EUR 10.5 mil in 2026, or 17.1% of sales. That’s compared to 12.0% average margin seen in last five years.
The company netted EUR 6.10 mil in 2026 implying ROE of 14.8% and ROCE of 11.1%. Again, the average figures were 9.23% and 6.84%, respectively when looking at the previous 5 years.
Chirana T. Injecta Group’s net debt amounted to EUR 11.9 mil at the end of 2026, or 28.3% of equity. When compared to EBITDA, net debt was 1.14x, down when compared to average of 1.95x seen in the last 5 years.
Chirana T. Injecta Group stock traded at EUR 29.5 per share at the end of 2026 resulting in a market capitalization of USD 34.6 mil. Over the previous five years, stock price grew by 0% or 0% a year on average. The closing price put stock at a 12-month trailing EV/EBITDA of 3.87x and price to earnings (PE) of 4.84x as of 2026.
Helgi Library 
